Collection
Special Issue: Statistical Methods for Cancer Immunotherapy
In this special issue of Statistics in Biosciences, 10 innovative and thought-provoking articles by forward-thinking statisticians cover a wide spectrum of relevant topics in the clinical development of cancer immunotherapies to address these mechanisms and challenges.
Editors
-
Bo Huang
PhD, Pfizer Inc, Groton, CT, USA
-
Naitee Ting
PhD, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA
Articles (11 in this collection)
-
-
-
-
-
-
A Bayesian Method for the Detection of Proof of Concept in Early Phase Oncology Studies with a Basket Design
Authors (first, second and last of 7)
-
PoD-TPI: Probability-of-Decision Toxicity Probability Interval Design to Accelerate Phase I Trials
Authors
-
Impact of Clinical Center Variation on Efficiency of Exploratory Umbrella Design
Authors (first, second and last of 4)
-
On the Use of Marker Strategy Design to Detect Predictive Marker Effect in Cancer Immunotherapy and Targeted Therapy
Authors (first, second and last of 5)
-
-
